期刊文献+

益气活血法在老年性黄斑变性治疗中的应用观察

Clinical observation of Yiqi Huoxue method in the treatment of senile macular degeneration
下载PDF
导出
摘要 目的:探讨益气活血法治疗湿性老年性黄斑变性的效果。方法:收治湿性老年性黄斑变性患者56例(68只眼),随机分为对照组和试验组,对照组采用葡糖糖酸锌溶液和维生素B_(12)片治疗,试验组在对照组基础上加益气活血法治疗,比较两组治疗效果。结果:治疗后,试验组视力稳定和视力提高人数明显高于对照组,视力下降人数明显低于对照组(P<0.05);治疗后,两组患者CNV复合体厚度和黄斑区视网膜厚度均降低,且试验组明显低于对照组(P<0.05)。结论:益气活血法治疗湿性老年性黄斑变性的效果显著。 Objective:To explore the clinical effect of Yiqi Huoxue method in the treatment of senile macular degeneration.Methods:56 patients(68 eyes) with senile macular degeneration were selected.They were randomly divided into the control group and the experimental group.The control group was treated with glucose acid zinc solution and vitamin B12 tablets.The experimental group was treated with Yiqi Huoxue method on the basis of the control group.We compared the treatment effect of two groups.Results:After treatment,in the experimental group,the number of stable vision and improved vision were significantly higher than the control group,and the number of visual acuity decrease was significantly lower than the control group(P<0.05).After treatment,the CNV complex thickness and the macular retinal thickness of the two groups were all reduced,and the experimental group was significantly lower than the control group(P<0.05).Conclusion:The clinical effect of Yiqi Huoxue method in the treatment of senile macular degeneration was significant.
作者 王鑫 Wang Xin(Ophthalmology Department,the Traditional Chinese Medicine Hospital of Kaifeng City,Henan Province 475000)
出处 《中国社区医师》 2016年第25期125-126,共2页 Chinese Community Doctors
关键词 益气活血法 湿性老年性黄斑变性 视网膜厚度 Yiqi Huoxue method Wet senile macular degeneration Retinal thickness
  • 相关文献

参考文献2

二级参考文献65

  • 1Jager RD,Mieler WF,Miller JW.Age-related maculardeg,eneration[J].N Eng I J Med,2008:358(24):2606-2617.
  • 2Naylor MD,Aiken LH,Kurtzman ET,et al.The care span:The importance of transitional care in achieving,health reform[J].Health AFF(Millwood),2011,30(4):746-754.
  • 3Marshall LL,Roach JM.Prevention and treatment of ag,e-related macular deg,eneration:an update for pharmacists[J].Consult Pharm,2013,28(11):723-737.
  • 4Chua PY,Mitrut I,Armbrecht AM,et al.Evaluating,patient discomfort,anxiety,and fear before and after ranibizumab intravitreous injection forwet a g,e-related macular de g,eneration[J].Arch Ophthalmol,2009,127(7):939-940.
  • 5sMITH W, ASSINK J, KLEIN R, MITCHELL P, KLAVER CC, KLEIN BE, et al. Risk factors for age-related macular degen- eration: Pooled fmdings from three continents [J]. Ophthal-mology, 2001,108 ( 4 ) : 697 -704.
  • 6LIM LS,MITCHELL P,SEDDON JM,HOLZ FG,TY W. Age-re- lated macular degeneration [J]. Lancet, 2012,379 ( 9827 ) : 1728-1738.
  • 7Group AREDS. Risk factors associated with age-related mac- ular degeneration [J]. Ophthalmology, 2000,107 ( 12 ) : 2224- 2232.
  • 8THOMPSON RB, REFFATTO V, BUNDY JG, KORTVELY E, FLINN JM, LANZIROTTI A, et at. Identification of hydroxyap- atite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye [J]. Proc Natl Acad Sci USA,2015,112(5) :1565-1570.
  • 9CHAKRAVARTHY U, AUGOOD C, BENTHAM GC, De JONG PT, RAHU M, SELAND J, et al. Cigarette smoking and age-re- lated macular degeneration in the EUREYE Study [J]. Oph- thalmoloau. 2007. 114 ( 6 ) : 1157 - 1163.
  • 10FINKEL T,HOLBROOK NJ. Oxidants, oxidative stress and the biology of ageing [J].Nature,2000,408 ( 6809 ) :239-247.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部